Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Safety and Effectiveness of D-Cycloserine in Children With Autism

Phase 3

Completed

Conditions: Autistic Disorder

Interventions: Drug: D-cycloserine
Drug: Placebo

First Posted Date: 2005-09-20

Last Posted Date: 2016-04-12

Lead Sponsor: Indiana University

Target Recruit Count: 80

Registration Number: NCT00198120

Locations: 🇺🇸
Riley Hospital for Children, Christian Sarkine Autism Treatment Center, Indianapolis, Indiana, United States

Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism

Phase 3

Completed

Conditions: Autistic Disorder

Interventions: Drug: Placebo
Drug: Aripiprazole
Drug: D-cycloserine

First Posted Date: 2005-09-20

Last Posted Date: 2019-04-09

Lead Sponsor: Indiana University

Target Recruit Count: 81

Registration Number: NCT00198107

Locations: 🇺🇸
Riley Hospital for Children, Christian Sarkine Autism Treatment Center, Indianapolis, Indiana, United States

e-CHAMP: Enhancing Care for Hospitalized Older Adults With Memory Problems

Not Applicable

Completed

Conditions: Delirium
Cognitive Impairment

Interventions: Behavioral: e-CHAMP (Enhancing Care for Hospitalized Older Adults with Cognitive Impairment)
Behavioral: Standard Care

First Posted Date: 2005-09-16

Last Posted Date: 2016-04-13

Lead Sponsor: Indiana University

Target Recruit Count: 424

Registration Number: NCT00182832

Locations: 🇺🇸
Wishard Memorial Hospital, Indianapolis, Indiana, United States

Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery

Phase 4

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: Amiodarone

First Posted Date: 2005-08-08

Last Posted Date: 2013-09-18

Lead Sponsor: Indiana University

Target Recruit Count: 130

Registration Number: NCT00127712

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Stepped Care for Depression and Musculoskeletal Pain

Phase 4

Completed

Conditions: Pain
Depression

Interventions: Drug: Usual Care
Behavioral: Stepped Care
Drug: Antidepressants

First Posted Date: 2005-07-11

Last Posted Date: 2017-05-09

Lead Sponsor: Indiana University

Target Recruit Count: 500

Registration Number: NCT00118430

Locations: 🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors
Bone Marrow Suppression
Drug/Agent Toxicity by Tissue/Organ

Interventions: Procedure: filgrastim
Biological: gene therapy
Drug: lomustine
Drug: procarbazine hydrochloride
Drug: vincristine sulfate
Procedure: in vitro-treated peripheral blood stem cell transplantation

First Posted Date: 2004-04-28

Last Posted Date: 2015-03-25

Lead Sponsor: Indiana University

Target Recruit Count: 10

Registration Number: NCT00005796

Locations: 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Hypertension in Hemodialysis

Not Applicable

Completed

Conditions: Hypertension
Left Ventricular Hypertrophy

Interventions: Other: Ultrafiltration

First Posted Date: 2003-08-27

Last Posted Date: 2011-03-28

Lead Sponsor: Indiana University

Target Recruit Count: 150

Registration Number: NCT00067665

Locations: 🇺🇸
Indiana University Affiliated Dialysis Unit, Indianapolis, Indiana, United States

Alzheimer's Disease Genetics Study

Recruiting

Conditions: Alzheimer Disease
Late Onset Alzheimer Disease
Dementia

First Posted Date: 2003-07-16

Last Posted Date: 2024-03-12

Lead Sponsor: Indiana University

Target Recruit Count: 10000

Registration Number: NCT00064870

Locations: 🇺🇸
Participants are being recruited from all over the United States, Multiple Locations, Indiana, United States

Treatment for Post-Stroke Depression

Phase 4

Completed

Conditions: Stroke
Depression

Interventions: Other: case management

First Posted Date: 2002-01-09

Last Posted Date: 2023-02-16

Lead Sponsor: Indiana University

Target Recruit Count: 188

Registration Number: NCT00029172

Locations: 🇺🇸
Roudebush VA Medical Center, Health Services Research and Development 11H, 1481 W. 10th Street, Indianapolis, Indiana, United States
🇺🇸
Indiana University Hospital, 550 N. University Blvd., Indianapolis, Indiana, United States
🇺🇸
Methodist Hospital of Indiana, 1601 N. Capitol, Indianapolis, Indiana, United States

and more 1 locations

Post-Treatment Effects of Naltrexone

Phase 4

Completed

Conditions: Alcoholism

First Posted Date: 2000-11-07

Last Posted Date: 2010-05-12

Lead Sponsor: Indiana University

Target Recruit Count: 160

Registration Number: NCT00006449

Locations: 🇺🇸
Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, Indiana, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy